Recent Updates
Recently added Catalysts
TECH Positive Sentiment

Bio-Techne to Present at Investor Conferences Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences: William Blair 45th Annual Growth...

Key Takeaway: Bio-Techne Corporation (NASDAQ: TECH) has announced its participation in several upcoming investor conferences, including the William Blair 45th Annual Growth Stock Conference and the Jefferies Global Healthcare Conference. These presentations provide an opportunity for Bio-Techne to connect with investors and showcase its innovative products. With a diverse portfolio of research and clinical diagnostic tools, the company has demonstrated strong financial performance, generating around $1.2 billion in net sales in fiscal 2024.
Price reaction · baseline $47.93 (2025-05-28 close) · hit after-hours · clean, no other TECH news in the window
day 0 close
+0.8%

Conference Participation Details

Jefferies Global Healthcare Conference
Date: November 18, 2025
Time: 11:30 a.m. GMT / 6:30 a.m. ET
Location: London
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

Market Sentiment Analysis

POSITIVE FACTORS

  • Bio-Techne is actively engaging with investors through multiple conferences.
  • The company's product portfolio supports significant scientific and clinical advancements.
  • Bio-Techne reported impressive net sales of approximately $1.2 billion in fiscal 2024.

Full Press Release Details

MINNEAPOLIS , May 29, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH ) today announced that it will present at the following investor conferences:
William Blair 45 th Annual Growth Stock Conference June 3, 2025 2:40 PM CDT
Jefferies Global Healthcare Conference June 4, 2025 3:45 PM EDT
Goldman Sachs 46 th Annual Global Healthcare Conference June 10, 2025 10:40 AM EDT
A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar .
About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH ) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at: Facebook , LinkedIn , Twitter or YouTube .

Frequently Asked Questions

When will Bio-Techne present at the William Blair conference?

Bio-Techne will present at the William Blair conference on June 3, 2025, at 2:40 PM CDT.

Where can I access Bio-Techne's live webcast?

The live webcast of Bio-Techne's presentations can be accessed via their Investor Relations website.

How much did Bio-Techne generate in net sales for fiscal 2024?

Bio-Techne generated approximately $1.2 billion in net sales during fiscal 2024.

What is Bio-Techne's primary focus?

Bio-Techne focuses on providing innovative tools and bioactive reagents for life sciences.

How many employees does Bio-Techne have worldwide?

Bio-Techne has approximately 3,100 employees globally.

Last updated: May 29, 2025